# Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

> **NCT01416714** · — · RECRUITING · sponsor: **University of Chicago** · enrollment: 1000 (estimated)

## Conditions studied

- Gastric Cancers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01416714
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2008-07-02
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416714, "Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01416714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*